Get started
ENLIVEXENLIVEXENLIVEX

ENLIVEX

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

ENLV trade ideas

ENLV Israel - Praying it doesnt break down this channelWith the evolution of covid variants, i believe this is one of the possible solution to serious covid reactions. It is competitors of course are vaccine makers. Are we going to keep relying on vaccine makers. Or can we rely on something like what ENLV has? Based on my research, ENLV is in the midst of trials and so far seems to be the only Israeli company, focusing on covid, that has gotten a subsidy from an Israel government agency. The phase 2 trials are being conducted in Israel and Europe. None so far in the US. However, it has recently filed a patent for the US. In the meantime, I hope that we will see more positive news. Which without regular positive news, this stock will likely head downwards.
TASE:ENLVLong
by oilyprata
$ENLV Target 17.10 for 31.34% $ENLV Target 17.10 for 31.34% Or next add level is at 8.94 Anywhere around here is a good place to add... — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed. GL and happy trading.
NASDAQ:ENLVLong
by SPYder_QQQueen_Trading
1
ADDED to $ENLV New Target 18.02 for 29.27% $ENLV Target 18.02 for 29.27% Or next add level is at 9.86 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed. GL and happy trading.
NASDAQ:ENLVLong
by SPYder_QQQueen_Trading
$ENLV Target 19.39 for 26.65% $ENLV Target 19.39 for 26.65% Or next add level is at anywhere around here but I can’t add yet. This one is actually really starting to look bullish... running out of steam on the down side... I am going to double my position here tomorrow, I think. There are a few other moves I'm thinking about but this one feels solid right now. — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed. GL and happy trading.
NASDAQ:ENLVLong
by SPYder_QQQueen_Trading
ENLV Enlivex and Mount Sinai Health System Announce Research Collaboration for the Development of Allocetra in Combination with Immune Checkpoint Inhibitors. In addition to the Sepsis for which it was developed, the drug Allocetra has other applications such as severe patients with Covid 19 ' autoimmune diseases. Indication Global Market Size Pre Clinical Phase Marketing Organ failure associated with Sepsis $33B Phase Ib Completed Phase IIb Initiation Q1 2021 ARDS associated with severe/critical COVID-19 / Non-COVID-19 ARDS $1B (COVID) $15B (ARDS) COVID-19 Phase II Ongoing COVID-19 Phase Ib completed. goog luck..... Solid tumors in combination with immune checkpoints $4B Q3 2021
NASDAQ:ENLVLong
by pureplanet
2
Long #ENLV above 18.50, COVID news#ENLV is in the news last week with regards to Covid-19 treatment. I would be looking at the 18.46 area for a retest, and possible entry if we find support. 100% measured move would take the breakout to 23.81 and ultimately that would be my first target. Id consider this trade still healthy above 15.49 and ultimately any lower than 14.54 i would stop out of a longer term position and consider the 10.72-12.32 for a reentry. Based on trend projection confluence and fib levels, id be looking to sell some shares at the 28.00 level If we happen to see price action above these levels, i would consider targeting 37$ down the road. The top of this trading range would be close to $45, Currently trading at 15.49
NASDAQ:ENLVLong
by TradingNomadic
ENLVSepsis is currently the number three cause of death in the Western world, after heart-lung failure and cancer. This is a market of more than $ 30 billion. The Enlv product was originally intended for the treatment of sepsis (sepsis) and is in 2nd place in drug trials. The drug developed by Enlv is supposed to over-activate the immune system in patients with infectious diseases whose condition is severe. In severe situations the immune system can lose control and get into a spin known as a cytokine storm and cause extensive damage to the body. Enlv has decided to expand product development in corona treatment as well, after it became clear that this virus could, in severe cases, cause a cytokine storm.
NASDAQ:ENLVLong
by pureplanet
ENLV, Cup-and-Handle Inverse (bearish)I found this pattern at tickeron website with the following data: STATUS = Confirmed CURRENT CONFIDENCE = 80% TARGET (EXIT) PRICE = 11.30 USD BREAKOUT (ENTRY) PRICE = 12.60 USD DISTANCE TO TARGET PRICE = 6.92% EMERGED ON = Oct 23, 11:00 AM (EDT) CONFIRMED ON = Oct 23, closing price WITH CONFIDENCE LEVEL = 87% The Inverted Cup­-and-­Handle (sometimes called Inverted Cup­-and-­Holder) pattern forms when prices rise then decline to create an upside-­down “U”­like shape (1, 2, 3, also known as the Cup), followed by a shorter relatively straight price increase that bounces from the right lip (from 3 to 4, creating the Handle). The rising handle forms as a result of mounting buying pressure created when the security retests a low at the right lip of the cup. Once the buyers give up, sellers take over and the security has the potential to decline rapidly. Trade idea If the price breaks out from the top pattern boundary, day traders and swing traders should trade with a DOWN trend. Consider selling the security short or buying a put option at the downward breakout level. To identify an exit, compute the target price by subtracting the pattern’s height (the difference between the highest price and the support levels) from the price at the right cup lip. The confirmation move is the breakout of the price below the right cup lip. To limit potential loss when price suddenly goes in the wrong direction, consider placing a stop order to buy back a short position or sell a put option at or above the breakout price.
NASDAQ:ENLVShort
by AlTorress
2
ENLV the only effective and safe treatment COVID-19 Trump is sick in Corona ( only effective and safe treatment If he needs to ) May God protects him!!! The company has the most effective and safe complex that currently exists to treat the disease. Even after developing the vaccine, the virus may change mutations and the vaccine will not be effective. And the only effective and safe treatment will be in the body's immune system as this company produces. Opinion only not professional advice.
NASDAQ:ENLVLong
by pureplanet
1